UP-NEXT (GOG-3049/ENGOT-Ov71-NSGO-CTU): A study of Upitifamab Rilsodotin (UpRi), a NaPi2b-directed antibody drug conjugate in platinum-sensitive recurrent ovarian cancer (1248) | Publicación